- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/30 - Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
Patent holdings for IPC class A61K 38/30
Total number of patents in this class: 489
10-year publication summary
|
29
|
35
|
38
|
33
|
33
|
35
|
42
|
35
|
38
|
18
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Oak Hill Bio Limited | 30 |
17 |
| Juvena Therapeutics, Inc. | 20 |
12 |
| Betavive Ltd. | 9 |
8 |
| Massachusetts Institute of Technology | 10290 |
7 |
| University of Vermont and State Agricultural College | 401 |
7 |
| Warsaw Orthopedic, Inc. | 2748 |
6 |
| New York University | 1850 |
6 |
| The University of Chicago | 1504 |
6 |
| Cavalry Biosciences, Inc. | 15 |
6 |
| The Regents of the University of California | 20868 |
5 |
| President and Fellows of Harvard College | 6111 |
5 |
| University of Florida Research Foundation, Inc. | 4194 |
5 |
| Amicus Therapeutics, Inc. | 354 |
5 |
| The Brigham and Women's Hospital, Inc. | 2296 |
5 |
| Caregen Co., Ltd. | 352 |
5 |
| IGF Oncology, LLC | 16 |
5 |
| Puretein Bioscience LLC | 17 |
5 |
| Rani Therapeutics, LLC | 192 |
5 |
| Shire Human Genetic Therapies, Inc. | 190 |
5 |
| Silver Creek Pharmaceuticals, Inc. | 32 |
5 |
| Other owners | 359 |